Genmab — April 2021

[Helge_LarsenPI-redaktør]

Langers Skarpe: Deltag i festen, men undgå tømmermænd og forlad den i tide

https://www.proinvestor.com/investornyt/674170/langers-skarpe-deltag-i-festen-men-undga-tommermaend-og-forlad-den-i-tide

[E_L]

Health Canada-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis / Dara https://www.newswire.ca/news-releases/darzalex-r-sc-becomes-the-first-and-only-health-canada-approved-treatment-for-patients-with-newly-diagnosed-light-chain-al-amyloidosis-a-rare-disease-849615211.html

[E_L]

CEO Jan van de Winkel rykker op på førstepladsen i Økonomisk Ugebrevs årlige CEO Performance-ranking. https://ugebrev.dk/ledelse/genmab-vinder-ceo-performance-redningsplan-blev-succes/

[E_L]

waiting for this, New trial - A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab https://clinicaltrials.gov/ct2/show/NCT04847596

[Bulder]

yes, pretty important these days

[E_L]

These results obtained after 12 months of maintenance therapy reveal the potential of D-VRd and D-R maintenance as a new treatment for patients with NDMM who are eligible for transplant.
https://multiplemyelomahub.com/medical-information/daratumumab-plus-vrd-vs-vrd-in-newly-diagnosed-mm-griffin-trial-updated-analysis

[E_L]

i expect this to be an area we will hear a lot more about , Dara maintanenance, we should be getting more and more data there. Also hope we will get some smoldering data soon. Next areas of expansion.

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[Sukkeralf]

DARZALEX SC Becomes the First and Only Health Canada-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis, A Rare Disease

[peter12]

Old news (15:12)

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Asien: Frygt for nye nedlukninger presser japanske selskaber https://www.proinvestor.com/investornyt/674191/asien-frygt-for-nye-nedlukninger-presser-japanske-selskaber

[Helge_LarsenPI-redaktør]

Genmab/DNB: Kursmål løftet 9 pct. https://www.proinvestor.com/investornyt/674193/genmab-dnb-kursmal-loftet-9-pct-gent

[Helge_LarsenPI-redaktør]

Tirsdagens danske avisuddrag med Danske Bank, Lego og Hummel https://www.proinvestor.com/investornyt/674194/tirsdagens-danske-avisuddrag-med-danske-bank-lego-og-hummel

[Plimsoller]

God morgen

[Helge_LarsenPI-redaktør]

Genmab/Deutsche Bank: Indleder med "køb" og kursmål på 2750 kr. https://www.proinvestor.com/investornyt/674199/genmab-deutsche-bank-indleder-med-kob-og-kursmal-pa-2750-kr

[E_L]

looking back, I have 7 changes from DNB within the last 6 months since early november lol

[kkjoel]

Yeah, noticed that as well. I guess that analyst has never heard of: "Time in the market beats timin' the market".

[E_L]

[kkjoel]

Btw, I had Deutsche with a previous target on 1580 from 20.02.2020. I suppose they later on at some point officially discontinued the coverage, as the newsitem says: "Genmab/Deutsche Bank: Indleder med.."?!